MARKET

TBPH

TBPH

Theravance Bioph
NASDAQ
19.50
-0.98
-4.79%
After Hours: 19.55 +0.05 +0.26% 19:15 02/09 EST
OPEN
20.51
PREV CLOSE
20.48
HIGH
20.60
LOW
19.35
VOLUME
548.20K
TURNOVER
--
52 WEEK HIGH
21.03
52 WEEK LOW
7.90
MARKET CAP
988.11M
P/E (TTM)
34.66
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TBPH last week (0202-0206)?
Weekly Report · 23h ago
A Glimpse Into The Expert Outlook On Theravance Biopharma Through 4 Analysts
Benzinga · 6d ago
Theravance Biopharma: Asymmetric Upside from Ampreloxetine on Top of a Cash-Flow-Positive Base Business Supports Buy Rating
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Theravance Biopharma (TBPH) and Align Tech (ALGN)
TipRanks · 6d ago
Weekly Report: what happened at TBPH last week (0126-0130)?
Weekly Report · 02/02 09:30
Noteworthy Wednesday Option Activity: TBPH, APH, LQDA
NASDAQ · 01/28 20:20
Weekly Report: what happened at TBPH last week (0119-0123)?
Weekly Report · 01/26 09:30
Theravance Biopharma management to meet with B. Riley
TipRanks · 01/23 15:05
More
About TBPH
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development and commercialization of medicines for the specialty respiratory and neurologic diseases. The Company operates through a single segment, namely, development and commercialization of human therapeutics. Its product, YUPELRI (revefenacin) inhalation solution, is a nebulized long-acting muscarinic antagonist used for the treatment of patients with chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps the muscles around the airway in the lungs stay relaxed to prevent symptoms, such as wheezing, shortness of breath, and others. Its Ampreloxetine, is a late-stage investigational norepinephrine reuptake inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension in patients with Multiple System Atrophy.

Webull offers Theravance Biopharma Inc stock information, including NASDAQ: TBPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TBPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TBPH stock methods without spending real money on the virtual paper trading platform.